Compounds > dihydroergotamine
Page last updated: 2024-08-21

dihydroergotamine and Day Blindness

dihydroergotamine has been researched along with Day Blindness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kelley, BJ; Kunkel, R; Samples, S1
Hommes, OR1

Other Studies

2 other study(ies) available for dihydroergotamine and Day Blindness

ArticleYear
PRES following administration of DHE in a patient with unsuspected pheochromocytoma.
    Headache, 2008, Volume: 48, Issue:8

    Topics: Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Headache; Humans; Hypertensive Encephalopathy; Male; Pheochromocytoma; Seizures; Vision Disorders

2008
[Vertebrobasilary insufficiency].
    Nederlands tijdschrift voor geneeskunde, 1977, May-28, Volume: 121, Issue:22

    Topics: Aged; Arterial Occlusive Diseases; Basilar Artery; Diabetes Complications; Dihydroergotamine; Female; Headache; Humans; Hypertension; Male; Middle Aged; Unconsciousness; Vertebral Artery; Vertigo; Vision Disorders

1977